Table 4 Effectiveness of iron supplementation according to the route of administration
Author | Year | Journal | Transfusion indication | Transfusion rate_IV (N, %) | Transfusion rate_Oral (N, %) | Hb_IV (g/dL) | Hb_Oral (g/dL) |
|---|---|---|---|---|---|---|---|
Biboulet et al. [22] | 2018 | Anesthesiology | Â | Â | Â | Pre-OP (14.9) POD 1D (12.6) POD 3D (12.6) POD 5D (13.4) | Pre-OP (13.9) POD 1D (12.2) POD 3D (11.6) POD 5D (12.3) |
Bisbe et al. [23] | 2014 | Br J Anaesth | Hb < 8 g/dL or acute anemia symptoms | 3 (5%) | 2 (3.2%) | Pre-OP (13.6 ± 0.9) POD 1D (10.5 ± 1.0) POD 4D (9.7 ± 1.3) POD 30D (11.5 ± 1.2) | Pre-OP (13.6 ± 0.9) POD 1D (10.5 ± 1.0) POD 4D (9.7 ± 1.1) POD 30D (11.0 ± 1.1) |
Gonzalez-Porras et al. [29] | 2009 | Transfus Med | Hb < 7 g/dL for healthy patients Hb < 8 g/dL for poor tolerance of anemiaHb < 9 g/dL for cardiac or respiratory failure | 10 (20.4%) | 29 (20%) | Pre-OP (13.3 ± 0.2) POD discharge (10.3 ± 0.8) | Pre-OP (14.3 ± 0.8) POD discharge (10.7 ± 0.1) |